Tartrazine in oral rehydration solutions.
D001391:Azo Compounds / Q000009:adverse effects*; D002648:Child; D004342:Drug Hypersensitivity / Q000209:etiology*; D005440:Fluid Therapy / Q000009:adverse effects*; D006801:Humans; D013645:Tartrazine / Q000009:adverse effects*
D001391:Azo Compounds; D013645:Tartrazine